|4Feb 18, 4:55 PM ET

Deutsch Barry M. 4

4 · XERIS PHARMACEUTICALS INC · Filed Feb 18, 2020

Insider Transaction Report

Form 4
Period: 2020-02-14
Deutsch Barry M.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2020-02-14$4.15/sh+9,639$40,00239,359 total
Footnotes (1)
  • [F1]Represents shares purchased in an underwritten public offering of the Issuer at the public offering price of $4.15 per share.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION